Further data on Nano Covax vaccine’s protective efficacy needed
The National Ethics Committee in Biomedical Research under the Ministry of Health has requested additional reports on the protective efficacy of the homegrown candidate COVID-19 vaccine Nano Covax, requiring that they should be submitted before 3pm on December 22 for review.
Hanoi (VNA) ꦆ- The National Ethics Committee inBiomedical Research under the Ministry of Health has requested additionalreports on the protective efficacy of the homegrown candidate COVID-19 vaccine Nano Covax, requiring that they should be submitted before 3pm on December 22 for review.
The ministry announced on December 20 that onDecember 16, the committee convened a meeting reviewing supplementary reports on the mid-term outcomes of the phase 3trial of Nano Covax as of November 30.
Accordingly, it concluded that Nano Covax met safetyrequirements based on data of the additional reports. It also met requirements on immunityproduction in accordance with the ministry’s professional guidelines.
🌃 However, more data on its efficacy are needed, the National Ethics Committee in Biomedical Research said.
Nano Covax, a recombinant spike proteinvaccine, is the forerunner in the race for domestically produced COVID-19vaccine, followed by COVIVAC from the Institute of Vaccines and BiologicMedical and mRNA vaccine ARCT-154 (by Arcturus and VinBioCare) juststarting phase 2 trials.
Developed by the Nanogen PharmaceuticalBiotechnology JSC based on recombinant DNA/protein technology, Nano Covax wentthrough the first-phase trial from December 18, 2020 and the second phase fromFebruary 26, 2021. The third phase started on June 11, 2021.
🎶 Results from the first two trial phases showedthat all volunteers developed antibodies against the coronavirus SARS-CoV-2./.
The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
Nanogen Pharmaceutical Biotechnology JSC has been asked to provide more data for consideration before a registration certificate of conditional circulation for its Nano Covax can be granted.
Nanogen Pharmaceutical Biotechnology JSC was asked to provide more information regarding safety, immunogenicity, and protection effects before a registration certificate of circulation for its Nano Covax can be granted, Deputy Minister of Health Tran Van Thuan has said.
The National Ethics Committee in Biomedical Research under the Ministry of Health on September 19 issued a press statement on its conclusions of a meeting one day earlier during which it looked into the mid-term phase 3 trial’s results of homegrown COVID-19 vaccine Nano Covax.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative image (Photo: Nanogen) 
